State of the Art and Perspectives in Antimicrobial Peptides

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".

Deadline for manuscript submissions: 30 November 2024 | Viewed by 1341

Special Issue Editor


E-Mail
Guest Editor
Department of Agricultural Sciences, University of Naples Federico II, 80055 Portici, Italy
Interests: antimicrobial peptide; self-assembling nanostructures based peptides; drug delivery
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Bacterial infections caused by ‘superbugs’ are increasing globally, and conventional antibiotics are becoming less effective against these bacteria. A strong modification of lifestyle is required since we risk reverting back to a pre-antibiotic era in terms of immunological protection. Within this context, antimicrobial peptides (AMPs), a class of small peptides that widely exist in nature and contribute to an organism’s defenses, have attracted researchers’ attention. Perspectives and applications are numerous and cover different fields. Although peptides present some weaknesses in membrane impermeability and poor stability in vivo, due to the intrinsic limitations of amino acids, extensive research has been carried out in terms of the discovery and optimization of peptide drugs in order to overcome these drawbacks. The use of chemical modification and integration of traditional lead peptide discovery methods with novel technologies, such as rational design models, provides a reliable approach for the development of effective and selective lead peptides in a short period of time. Moreover, the design of peptide-based nano-systems opens the door to new and important scenarios.

Prof. Dr. Annarita Falanga
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antimicrobial peptides
  • AMPs
  • chemical modification of AMPs
  • function
  • structure
  • synthesis

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 4186 KiB  
Article
Functional Analyses of Three Targeted DNA Antimicrobial Peptides Derived from Goats
by Aili Wang, Mengying Zhou, Qian Chen, Hui Jin, Gaochi Xu, Ruiyin Guo, Jianmin Wang and Ren Lai
Biomolecules 2023, 13(10), 1453; https://doi.org/10.3390/biom13101453 - 27 Sep 2023
Viewed by 987
Abstract
With the increase in drug-resistant bacteria, new antibacterial drugs have emerged as a prominent area of research and development. Antimicrobial peptides (AMPs), as innate immune agents, have garnered significant attention due to their potent, rapid, and broad-spectrum antibacterial activity. This study focused on [...] Read more.
With the increase in drug-resistant bacteria, new antibacterial drugs have emerged as a prominent area of research and development. Antimicrobial peptides (AMPs), as innate immune agents, have garnered significant attention due to their potent, rapid, and broad-spectrum antibacterial activity. This study focused on investigating the functionality of three AMPs (CATH 1, CATH 2, and MAP34-B) derived from goat submandibular glands. Among these AMPs, CATH 2 and MAP34-B exhibited direct antibacterial activity against both Gram-negative and Gram-positive bacteria, primarily targeting the bacterial membrane. Additionally, these two AMPs were found to have the potential to induce reactive oxygen species (ROS) production in bacterial cells and interact with bacterial genome DNA, which may play a crucial role in their mechanisms of action. Furthermore, both CATH 1 and CATH 2 demonstrated significant antioxidant activity, and all three AMPs exhibited potential anti-inflammatory activity. Importantly, the cytotoxic activity of these AMPs against mammalian cells was found to be weak, and their hemolytic activity was extremely low. Overall, the characteristics of these three AMPs found in goat submandibular glands offer new insights for the study of host protection from an immunological perspective. They hold promise as potential candidates for the development of novel antibacterial agents, particularly in the context of combating drug-resistant bacteria. Full article
(This article belongs to the Special Issue State of the Art and Perspectives in Antimicrobial Peptides)
Show Figures

Figure 1

Back to TopTop